MedPath

RYBELSUS 7 MG COMPRIMIDOS

RYBELSUS 7 MG COMPRIMIDOS

Commercialized
Register Number

1201430005

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

May 5, 2020

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201430005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

SEMAGLUTIDAActive
Quantity: 7 mg
Name: SEMAGLUTIDA

ATC CLASSIFICATION (3)

A10B
A10BJ
A10BJ06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.